-
EP2914274
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2914274
| EP2914274 - GENETICALLY-MODIFIED PROBIOTIC FOR TREATMENT OF PHENYLKETONURIA [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.06.2017 Database last updated on 13.07.2024 | |
| Former | Request for examination was made Status updated on 26.02.2017 | Most recent event Tooltip | 30.06.2017 | Application deemed to be withdrawn | published on 02.08.2017 [2017/31] | Applicant(s) | For all designated states The Sydney Children's Hospital Network (Randwick and Westmead) CNR Hawkesbury Road & Hainsworth Street Westmead NSW 2145 / AU | [2015/37] | Inventor(s) | 01 /
AL-HAFID, Naz Western Sydney Genetics Program Children's Hospital at Westmead Cnr Hawkesbury Road&Hainsworth Street Westmead New South Wales 2145 / AU | 02 /
CHRISTODOULOU, John Western Sydney Genetics Program Children's Hospital at Westmead Cnr Hawkesbury Road&Hainsworth Street Westmead New South Wales 2145 / AU | 03 /
TONG, Xing Zhang Western Sydney Genetics Program Children's Hospital at Westmead Cnr Hawkesbury Road&Hainsworth Street Westmead New South Wales 2145 / AU | [2015/37] | Representative(s) | HGF 4th Floor Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | [N/P] |
| Former [2015/37] | Armstrong, Iain Cheshire HGF Limited 4th Floor, Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | Application number, filing date | 13850386.7 | 01.11.2013 | [2015/37] | WO2013AU01262 | Priority number, date | AU20120904813 | 01.11.2012 Original published format: AU 2012904813 | [2015/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014066945 | Date: | 08.05.2014 | Language: | EN | [2014/19] | Type: | A1 Application with search report | No.: | EP2914274 | Date: | 09.09.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.05.2014 takes the place of the publication of the European patent application. | [2015/37] | Search report(s) | International search report - published on: | AU | 08.05.2014 | (Supplementary) European search report - dispatched on: | EP | 21.06.2016 | Classification | IPC: | A61K35/74, C12N1/21, A61K48/00, A61P3/00, A61K38/51, A61K35/744, A61K35/747, A61K35/741, C12N9/88, C12N15/62 | [2016/29] | CPC: |
A61K35/747 (EP,US);
A61K35/741 (EP,US);
A61K35/744 (EP,US);
A61K38/51 (EP,US);
A61P3/00 (EP);
C12N15/625 (EP,US);
|
| Former IPC [2015/37] | A61K35/74, C12N1/21 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/37] | Title | German: | GENETISCH VERÄNDERTES PROBIOTIKUM ZUR BEHANDLUNG VON PHENYLKETONURIE | [2015/37] | English: | GENETICALLY-MODIFIED PROBIOTIC FOR TREATMENT OF PHENYLKETONURIA | [2015/37] | French: | PROBIOTIQUE MODIFIÉ GÉNÉTIQUEMENT POUR LE TRAITEMENT DE LA PHÉNYLCÉTONURIE | [2015/37] | Entry into regional phase | 29.05.2015 | National basic fee paid | 29.05.2015 | Search fee paid | 29.05.2015 | Designation fee(s) paid | 29.05.2015 | Examination fee paid | Examination procedure | 29.05.2015 | Examination requested [2015/37] | 11.02.2016 | Amendment by applicant (claims and/or description) | 19.01.2017 | Application deemed to be withdrawn, date of legal effect [2017/31] | 27.02.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/31] | Fees paid | Renewal fee | 12.10.2015 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.11.2016 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ ] - No further relevant documents disclosed | International search | [X]CN101586111 (BEIJING SANYUAN GENE ENGINEERI [CN]); | [X]CN1154845 (BEIJING RED CROSS CHAOYANG HOS [CN]) | [X] - CHRISTODOULOU J ET AL., "Enzyme substitution therapy for phenylketonuria delivered orally using a genetically modified probiotic: proof of principle", ABSTRACT NUMBER 166 PRESENTED AT THE 62ND ANNUAL MEETING OF THE AMERICAN SOCIETY OF HUMAN GENETICS, SAN FRANCISCO, CALIFORNIA., (20121108), XP055264422 | [X] - CHEN X. ET AL., "High-level expression of phenylalanine ammonia-lyase in Lactococcus lactis via synthesized sequence based on bias codons", CHINESE JOURNAL OF BIOTECHNOLOGY, (2006), vol. 22, no. 2, pages 187 - 190, XP022857531 DOI: http://dx.doi.org/10.1016/S1872-2075(06)60022-8 | [X] - LIU J. ET AL., "Study on a novel strategy to treatment of phenylketonuria", ART CELLS BLOOD SUBS AND IMMOB BIOTECH, (2002), vol. 30, no. 4, pages 243 - 257, XP009172887 DOI: http://dx.doi.org/10.1081/BIO-120006117 |